Risvodetinib, an investigational c-Abl inhibitor, met its primary safety and tolerability end points and showed promising signals of functional and pathologic improvement in a 12-week, phase 2 study of patients with early and untreated Parkinson…
Category: 6. Business
-
Israeli firm thwarts Jaguar Land Rover cyberattack
Israeli firm thwarts Jaguar Land Rover cyberattack | The Jerusalem PostJerusalem Post/Business & InnovationIsraeli expert says the hit on Jaguar Land Rover was “no ordinary cyberattack,” with lessons for supply chains and factory floors…
Continue Reading
-
Undiscovered Gems In Australia To Watch This October 2025
As the Australian market experiences a slight downturn following a bullish streak, investors are closely watching how economic indicators and global events, such as the U.S. government shutdown and fluctuating commodity prices, impact…
Continue Reading
-
Larry Summers praises Ford CEO Jim Farley’s concept of the essential economy because it doesn’t ‘fetishize manufacturing’
Former Treasury Secretary Larry Summers said Ford CEO Jim Farley’s idea of the “essential economy” is a good concept as it doesn’t focus narrowly on just factory work.
Amid fears that AI will wipe out large swaths of white-collar work,…
Continue Reading
-
Establishing network pharmacology between natural polyphenols and isch
Sudakshina Dutta,1 Arunkumar Subramanian,1 Vinoth Kumarasamy,2 Tamilanban T,1,3 M Yasmin Begum,4 Mahendran Sekar,5 Vetriselvan Subramaniyan,6 Siew Hua Gan,5 Ling Shing Wong,7 Adel Al Fatease,4 Yuan Seng Wu,8 Amrita Muralikrishnan5
1Department of…
Continue Reading
-
A significant week for hope in the Middle East
This article is an on-site version of our The Week Ahead newsletter. Subscribers can sign up here to get the newsletter delivered every Sunday. Explore all of our newsletters here
Hello and welcome to the working week.
The Nobel committee will on…
Continue Reading
-
The Future in Motion Since 1998 ™
EDITOR’S PICK
E1 Lagos Grand Prix: Where Speed Meets Sustainability on the Water
04 Oct 2025 | Synopsis
The E1 Lagos Grand Prix electrified Africa’s waterfront with…Continue Reading
-
Prognosis Strategy Exhibits Similar Transplant Outcomes in Select Patients
Among patients with hematologic cancers unlikely to find a human leukocyte antigen (HLA)–matched unrelated donor (MUD), no differences in transplant outcomes were found when a donor search prognosis strategy was used vs patients very likely to…
Continue Reading
-
Immunotherapy Success Rate for Ovarian Cancer: What Patients Need to Know in 2025
The immunotherapy success rate for ovarian cancer has become an increasingly important topic in modern oncology. Ovarian cancer remains one of the most lethal gynecologic malignancies worldwide, with more than 313,000 new cases…
Continue Reading
